VAERS reports by lot

Moderna COVID-19 lot 031620A: VAERS reports

35 VAERS reports list lot 031620A as a Moderna COVID-19 vaccine, received between 2021-02-01 and 2022-08-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
14%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4029%
Neurological2115%
Gastrointestinal1511%
Musculoskeletal1410%
Injection-site / Local reaction139%
Cardiac / Cardiovascular129%
Dermatological (non-injection-site)118%
Respiratory32%
Psychiatric / Neuropsychiatric32%
Thrombotic / Hematological21%
Allergic / Anaphylactic21%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida9
Pennsylvania4
Illinois3
Rhode Island2
North Carolina2
Maine1
Arizona1
Minnesota1
Mississippi1
Wisconsin1
Tennessee1
Nevada1

Reports by month received

2021-029
2021-035
2021-042
2021-0813
2021-093
2021-111
2022-041
2022-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.